Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Antihypertensive Drugs Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Surging prevalence of hypertension, along with the growing geriatric population
5.1.1.2. Increase in healthcare expenditure worldwide
5.1.1.3. Growing consumer awareness of early diagnosis and treatment
5.1.2. Restraints
5.1.2.1. Stringent approval process and huge costs involved in drug development
5.1.3. Opportunities
5.1.3.1. Introduction of a new class of antihypertensive drugs
5.1.3.2. Surge in approvals of novel drugs from regulatory bodies
5.1.4. Challenges
5.1.4.1. Concern regarding adverse health outcomes of antihypertensive drugs
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Antihypertensive Drugs Market, by Drug Class
6.1. Introduction
6.2. Alpha-Blockers
6.3. Angiotensin Converting Enzyme Inhibitors
6.4. Angiotensin Receptor Blockers
6.5. Beta-Blockers
6.6. Calcium Channel Blockers
6.7. Diuretics
6.8. Renin Inhibitors
6.9. Vasodilators

7. Antihypertensive Drugs Market, by Form
7.1. Introduction
7.2. Intravenous Injections
7.3. Oral Tablets/Capsules
7.4. Transdermal Patches

8. Antihypertensive Drugs Market, by Indication
8.1. Introduction
8.2. Primary Hypertension
8.3. Secondary Hypertension

9. Antihypertensive Drugs Market, by Distribution Channel
9.1. Introduction
9.2. Offline
9.3. Online

10. Antihypertensive Drugs Market, by End-User
10.1. Introduction
10.2. Home Care Facilities
10.3. Hospitals & Clinics

11. Americas Antihypertensive Drugs Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Antihypertensive Drugs Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Antihypertensive Drugs Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player

15. Competitive Portfolio
15.1. Key Company Profiles
15.1.1. Abbott Laboratories
15.1.2. Alembic Pharmaceuticals Limited
15.1.3. Alkem Laboratories
15.1.4. Apikos Pharma
15.1.5. AstraZeneca PLC
15.1.6. Bayer AG
15.1.7. Boehringer Ingelheim International GmbH
15.1.8. Centurion Remedies Private Limited
15.1.9. Daiichi Sankyo Co., Ltd.
15.1.10. Dr. Reddy’s Laboratories
15.1.11. F. Hoffmann-La Roche AG
15.1.12. Gilead Sciences, Inc.
15.1.13. Glenmark Pharmaceuticals Ltd.
15.1.14. Johnson & Johnson Services, Inc.
15.1.15. Lupin Ltd.
15.1.16. Merck & Co., Inc.
15.1.17. Novartis AG
15.1.18. Sanofi S.A.
15.1.19. Saphnix Lifesciences
15.1.20. Schwitz Biotech
15.1.21. Sun Pharmaceutical Industries Limited
15.1.22. Takeda Pharmaceutical Company Limited
15.1.23. Teva Pharmaceutical Industries Ltd.
15.1.24. United Therapeutics Corporation
15.1.25. Zydus Lifesciences Limited
15.2. Key Product Portfolio

16. Appendix
16.1. Discussion Guide
16.2. License & Pricing



List of Figures

FIGURE 1. ANTIHYPERTENSIVE DRUGS MARKET RESEARCH PROCESS
FIGURE 2. ANTIHYPERTENSIVE DRUGS MARKET SIZE, 2023 VS 2030
FIGURE 3. ANTIHYPERTENSIVE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. ANTIHYPERTENSIVE DRUGS MARKET DYNAMICS
FIGURE 7. ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2023 VS 2030 (%)
FIGURE 8. ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY FORM, 2023 VS 2030 (%)
FIGURE 10. ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 12. ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 14. ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 16. ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. ANTIHYPERTENSIVE DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 26. ANTIHYPERTENSIVE DRUGS MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. ANTIHYPERTENSIVE DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
TABLE 3. ANTIHYPERTENSIVE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 6. ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY ALPHA-BLOCKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY ANGIOTENSIN CONVERTING ENZYME INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY ANGIOTENSIN RECEPTOR BLOCKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY BETA-BLOCKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DIURETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY RENIN INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY VASODILATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 15. ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY INTRAVENOUS INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY ORAL TABLETS/CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY TRANSDERMAL PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 19. ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY PRIMARY HYPERTENSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY SECONDARY HYPERTENSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 22. ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 25. ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY HOME CARE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 43. CANADA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 44. CANADA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 45. CANADA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 46. CANADA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 47. CANADA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 48. MEXICO ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 49. MEXICO ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 50. MEXICO ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 51. MEXICO ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 52. MEXICO ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 64. ASIA-PACIFIC ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 68. AUSTRALIA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 69. AUSTRALIA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 70. CHINA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 71. CHINA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 72. CHINA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 73. CHINA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 74. CHINA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. INDIA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 76. INDIA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 77. INDIA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 78. INDIA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 79. INDIA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 83. INDONESIA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 84. INDONESIA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. JAPAN ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 86. JAPAN ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 87. JAPAN ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 88. JAPAN ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. JAPAN ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 94. MALAYSIA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 95. PHILIPPINES ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 99. PHILIPPINES ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 100. SINGAPORE ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 104. SINGAPORE ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 109. SOUTH KOREA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 113. TAIWAN ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 114. TAIWAN ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. THAILAND ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 116. THAILAND ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 117. THAILAND ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 118. THAILAND ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 119. THAILAND ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 123. VIETNAM ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 124. VIETNAM ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 131. DENMARK ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 132. DENMARK ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 133. DENMARK ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 134. DENMARK ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 135. DENMARK ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 136. EGYPT ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 137. EGYPT ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 138. EGYPT ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 139. EGYPT ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 140. EGYPT ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 141. FINLAND ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 142. FINLAND ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 143. FINLAND ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 144. FINLAND ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. FINLAND ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 146. FRANCE ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 147. FRANCE ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 148. FRANCE ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 149. FRANCE ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 150. FRANCE ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 151. GERMANY ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 152. GERMANY ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 153. GERMANY ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 154. GERMANY ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 155. GERMANY ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 159. ISRAEL ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 160. ISRAEL ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 161. ITALY ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 162. ITALY ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 163. ITALY ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 164. ITALY ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 165. ITALY ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 169. NETHERLANDS ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 170. NETHERLANDS ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 174. NIGERIA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 175. NIGERIA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 176. NORWAY ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 177. NORWAY ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 178. NORWAY ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 179. NORWAY ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 180. NORWAY ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 181. POLAND ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 182. POLAND ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 183. POLAND ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 184. POLAND ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 185. POLAND ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 186. QATAR ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 187. QATAR ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 188. QATAR ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 189. QATAR ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 190. QATAR ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 206. SPAIN ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 207. SPAIN ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 208. SPAIN ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 209. SPAIN ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 210. SPAIN ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 215. SWEDEN ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 216. SWITZERLAND ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 219. SWITZERLAND ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 220. SWITZERLAND ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 221. TURKEY ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 222. TURKEY ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 223. TURKEY ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 224. TURKEY ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 225. TURKEY ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM ANTIHYPERTENSIVE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 236. ANTIHYPERTENSIVE DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 237. ANTIHYPERTENSIVE DRUGS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 238. ANTIHYPERTENSIVE DRUGS MARKET LICENSE & PRICING